Under physiological conditions, CD38 is expressed at low levels on immune cells (1), while plasma cells in both healthy individuals and patients with multiple myeloma (MM) show significantly higher CD38 expression (5, 6). This evidence concerns the gene CD38 and Miyoshi myopathy.